First Wave BioPharma Statistics
Share Statistics
First Wave BioPharma has 2.03M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 2.03M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,631 |
| FTD / Avg. Volume | 2.25% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.09 and the forward
PE ratio is null.
First Wave BioPharma's PEG ratio is
0.
| PE Ratio | -0.09 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.39 |
| P/FCF Ratio | -0.11 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
First Wave BioPharma has an Enterprise Value (EV) of -1.47M.
| EV / Sales | 0 |
| EV / EBITDA | 0.09 |
| EV / EBIT | 0.12 |
| EV / FCF | 0.11 |
Financial Position
The company has a current ratio of 1.58,
with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.58 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | -0.05 |
| Debt / FCF | -0.06 |
| Interest Coverage | 702.08 |
Financial Efficiency
Return on Equity is -438.39% and Return on Invested Capital is -356.02%.
| Return on Equity | -438.39% |
| Return on Assets | -229.47% |
| Return on Invested Capital | -356.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,754,998.11 |
| Employee Count | 9 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -1.99% in the
last 52 weeks. The beta is 1.28, so First Wave BioPharma's
price volatility has been higher than the market average.
| Beta | 1.28 |
| 52-Week Price Change | -1.99% |
| 50-Day Moving Average | 2.82 |
| 200-Day Moving Average | 4.96 |
| Relative Strength Index (RSI) | 30.29 |
| Average Volume (20 Days) | 72,481 |
Income Statement
| Revenue | n/a |
| Gross Profit | -29.27K |
| Operating Income | -15.77M |
| Net Income | -15.79M |
| EBITDA | -15.74M |
| EBIT | -15.82M |
| Earnings Per Share (EPS) | -46.96 |
Full Income StatementBalance Sheet
The company has 3.71M in cash and 826.84K in
debt, giving a net cash position of 2.88M.
| Cash & Cash Equivalents | 3.71M |
| Total Debt | 826.84K |
| Net Cash | 2.88M |
| Retained Earnings | -184.33M |
| Total Assets | 91.13M |
| Working Capital | 1.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -12.38M
and capital expenditures -500K, giving a free cash flow of -12.88M.
| Operating Cash Flow | -12.38M |
| Capital Expenditures | -500K |
| Free Cash Flow | -12.88M |
| FCF Per Share | -38.29 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
